DK0912195T3 - Vaccine indeholdende antigener bundet til bærestoffer gennem labile bindinger - Google Patents

Vaccine indeholdende antigener bundet til bærestoffer gennem labile bindinger

Info

Publication number
DK0912195T3
DK0912195T3 DK97927484T DK97927484T DK0912195T3 DK 0912195 T3 DK0912195 T3 DK 0912195T3 DK 97927484 T DK97927484 T DK 97927484T DK 97927484 T DK97927484 T DK 97927484T DK 0912195 T3 DK0912195 T3 DK 0912195T3
Authority
DK
Denmark
Prior art keywords
antigen
carriers
preparations
vaccine containing
labile
Prior art date
Application number
DK97927484T
Other languages
English (en)
Inventor
Wilhelmus Martinus Maria Schaaper
Kristian Dalsgaard
Robert Hans Meloen
Nico Johannes Christia Beekman
Original Assignee
Pepscan Systems Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pepscan Systems Bv filed Critical Pepscan Systems Bv
Application granted granted Critical
Publication of DK0912195T3 publication Critical patent/DK0912195T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6018—Lipids, e.g. in lipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
DK97927484T 1996-06-25 1997-06-24 Vaccine indeholdende antigener bundet til bærestoffer gennem labile bindinger DK0912195T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96201766 1996-06-25
PCT/NL1997/000354 WO1997049425A1 (en) 1996-06-25 1997-06-24 Vaccine comprising antigens bound to carriers through labile bonds

Publications (1)

Publication Number Publication Date
DK0912195T3 true DK0912195T3 (da) 2009-05-18

Family

ID=8224113

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97927484T DK0912195T3 (da) 1996-06-25 1997-06-24 Vaccine indeholdende antigener bundet til bærestoffer gennem labile bindinger

Country Status (10)

Country Link
EP (1) EP0912195B1 (da)
JP (1) JP4651753B2 (da)
AT (1) ATE421331T1 (da)
AU (1) AU732085B2 (da)
BR (1) BR9709993A (da)
CA (1) CA2260761C (da)
DE (1) DE69739233D1 (da)
DK (1) DK0912195T3 (da)
NZ (1) NZ333562A (da)
WO (1) WO1997049425A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6846968B1 (en) 1988-02-26 2005-01-25 Large Scale Biology Corporation Production of lysosomal enzymes in plants by transient expression
US5907030A (en) 1995-01-25 1999-05-25 University Of Southern California Method and compositions for lipidization of hydrophilic molecules
KR100691315B1 (ko) * 1996-09-26 2007-03-12 유니버시티 오브 써던 캘리포니아 친수성 분자를 지질화시키기 위한 방법 및 조성물
GB9915074D0 (en) * 1999-06-28 1999-08-25 Cortecs Plc Ligand-binding composition
US6730306B1 (en) * 2000-03-08 2004-05-04 Large Scale Biology Corporation Parvovirus vaccine as viral coat protein fusions
DK1377320T3 (da) 2001-04-04 2009-02-09 Nordic Vaccine Technology As Polynukleotidbindingskomplekser omfattende steroler og saponiner
AU2003243663A1 (en) * 2002-06-20 2004-01-06 The Trustees Of The University Of Pennsylvania Vaccines for suppressing ige-mediated allergic disease and methods for using the same
CA2743950A1 (en) * 2008-11-18 2010-05-27 The University Of Queensland Peptide conjugates for suppressing an immune response, methods of making and uses therefor
WO2011123042A1 (en) * 2010-04-01 2011-10-06 Independent Pharmaceutica Ab Vaccination procedure and products for use therein

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3937412A1 (de) 1989-11-10 1991-05-16 Hoechst Ag Synthetische vakzine zur spezifischen induktion zytotoxischer t-lymphozyten
NL8900726A (nl) * 1989-03-23 1990-10-16 Stichting Centr Diergeneeskund Peptide, immunogene samenstelling en vaccin- of geneesmiddelpreparaat; werkwijze voor het immuniseren van een zoogdier tegen lhrh, en werkwijze voor het verbeteren van de vleeskwaliteit van varkens.
US5256641A (en) 1990-11-01 1993-10-26 State Of Oregon Covalent polar lipid-peptide conjugates for immunological targeting
EP0491077A1 (en) * 1990-12-19 1992-06-24 Medeva Holdings B.V. A composition used as a therapeutic agent against chronic viral hepatic diseases
DE4101394A1 (de) * 1991-01-18 1992-07-23 Medor Lab Fuer Biochemie Und K Verfahren zum koppeln von kohlenhydraten an traeger, insbesondere proteine
EP0596959B1 (en) * 1991-07-26 2000-03-29 Commonwealth Scientific And Industrial Research Organisation Self-adjuvanting peptide vaccine delivery system and production thereof
US5785974A (en) * 1993-01-23 1998-07-28 Immunologia Y Genetica Aplicada, S.A. Synthetic peptides and vaccines against parvovirus
WO1994025060A1 (en) * 1993-04-27 1994-11-10 Ladd Anna E Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
ES2210262T3 (es) 1993-09-22 2004-07-01 Henry M. Jackson Foundation For The Advancement Of Military Medicine Procedimiento que permite activar un glucido soluble con la ayuda de nuevos reactivos cianilantes para producir estructuras inmunogenas.

Also Published As

Publication number Publication date
CA2260761A1 (en) 1997-12-31
NZ333562A (en) 2001-04-27
DE69739233D1 (de) 2009-03-12
ATE421331T1 (de) 2009-02-15
BR9709993A (pt) 1999-08-10
EP0912195B1 (en) 2009-01-21
AU732085B2 (en) 2001-04-12
CA2260761C (en) 2011-05-03
JP2000513353A (ja) 2000-10-10
AU3193897A (en) 1998-01-14
EP0912195A1 (en) 1999-05-06
WO1997049425A1 (en) 1997-12-31
JP4651753B2 (ja) 2011-03-16

Similar Documents

Publication Publication Date Title
WO1995029193A3 (en) Melanoma antigens
EP1028749A4 (en) ENTEROCOCCUS ANTIGENS AND VACCINE
CA2378866A1 (en) Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens
RU95105991A (ru) Конъюгат, вакцина, способы усиления иммуногенности, способы иммунизации
WO2000020027A3 (en) Methods for therapeutic vaccination
WO2005007673A3 (en) Immunogenic peptides
CA2912496C (en) Immunogenic composition for use in therapy
AU3193897A (en) Vaccine comprising antigens bound to carriers through labile bonds
ATE370745T1 (de) Verbesserte polysaccharid- und glykokonjugat- vakzine
DE69534382D1 (de) Peptide, verwendet als träger in immunogenen konstrukten, die in der entwicklung synthetischer impfstoffe geeignet sind
EP1124576A2 (en) Method for preparing solid phase conjugate vaccines
Rauly et al. Carrier properties of a protein derived from outer membrane protein A of Klebsiella pneumoniae
MX9801089A (es) Proteina hibrida que comprende epitopes estimulantes de celula auxiliar t y epitopes de celula b de la proteina de membrana externa mayor chlamydia trachomatis y su uso como vacuna.
Coughlin et al. Adjuvant activity of QS-21 for experimental E. coli 018 polysaccharide vaccines
NZ500151A (en) A general method for attaching DNA molecule comprising non-antibody target molecule (eg. CTLA-4 or L-selectin), antigen or epitope sequence, and optionally a polypeptide sequence
AU4803785A (en) Cross-reactive and protective epitopes of circumsporozoite proteins
DK1035133T3 (da) Fusionsproteiner, der omfatter bærere, som kan inducere et dobbelt immunrespons
CA2404111C (en) A polysaccharide-polypeptide conjugate
Skea et al. Adhesion-mediated enhancement of the adjuvant activity of alum
Raya et al. A prime-boost regime that combines Montanide ISA720 and Alhydrogel to induce antibodies against the HIV-1 derived multiepitope polypeptide TAB9
US6956119B2 (en) Polysaccharide-polypeptide conjugate
DE60016806D1 (de) Selfantigen-impfstoffe zur behandlung von b-zell lymphomen und sonstigen krebsen
Lovgren Construction and potential of the iscom as immunogen.
DE69322960D1 (de) Empfängnisverhütender impfstoff
IT1226728B (it) Coniugato peptidico immunologicamente attivo utile come vaccino antimalaria e metodo di immunizzazione impiegante lo stesso